AhR-deficiency as a cause of demyelinating disease and inflammation

Ludmila Juricek(Délégation Paris 5), Julie Carcaud(Délégation Paris 5), Alice Pelhaître(Délégation Paris 5), Thorfinn T. Riday(Délégation Paris 5), Aline Chevallier(Délégation Paris 5), Justine Lanzini(Délégation Paris 5), Nicolas Auzeil(Délégation Paris 5), Olivier Laprévôte(Délégation Paris 5), Florent Dumont(Délégation Paris 5), Sébastien Jacques(Délégation Paris 5), Frank Letourneur(Délégation Paris 5), Charbel Massaad(Délégation Paris 5), Cendra Agulhon(Délégation Paris 5), Robert Barouki(Délégation Paris 5), Mathieu Beraneck(Délégation Paris 5), Xavier Coumoul(Délégation Paris 5)
Scientific Reports
August 23, 2017
Cited by 65Open Access
Full Text

Abstract

The Aryl hydrocarbon Receptor(AhR) is among the most important receptors which bind pollutants; however it also regulates signaling pathways independently of such exposure. We previously demonstrated that AhR is expressed during development of the central nervous system(CNS) and that its deletion leads to the occurrence of a congenital nystagmus. Objectives of the present study are to decipher the origin of these deficits, and to identify the role of the AhR in the development of the CNS. We show that the AhR-knockout phenotype develops during early infancy together with deficits in visual-information-processing which are associated with an altered optic nerve myelin sheath, which exhibits modifications in its lipid composition and in the expression of myelin-associated-glycoprotein(MAG), a cell adhesion molecule involved in myelin-maintenance and glia-axon interaction. In addition, we show that the expression of pro-inflammatory cytokines is increased in the impaired optic nerve and confirm that inflammation is causally related with an AhR-dependent decreased expression of MAG. Overall, our findings demonstrate the role of the AhR as a physiological regulator of myelination and inflammatory processes in the developing CNS. It identifies a mechanism by which environmental pollutants might influence CNS myelination and suggest AhR as a relevant drug target for demyelinating diseases.


Related Papers

No related papers found

Powered by citation graph analysis